Total planned funding: $162,201,136
Allocations
Countries/Regions
India | $162,201,136 |
Organizational Types
Unknown | $68,029,699 |
NGO | $45,459,099 |
Own Agency | $26,074,454 |
University | $15,182,112 |
Private Contractor | $2,589,272 |
Multi-lateral Agency | $2,200,000 |
FBO | $1,100,000 |
Host Country Government Agency | $939,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $55,160,061 |
Prevention | $44,606,787 |
Care | $24,845,805 |
Management and Operations | $19,043,187 |
Testing | $10,427,031 |
Treatment | $8,118,265 |
Budget Codes
OHSS: Health Systems Strengthening | $30,763,933 |
HVOP: Sexual Prevention: Other Sexual Prevention | $24,165,152 |
HVSI: Strategic Information | $20,159,606 |
HVMS: Management and Operations | $19,043,187 |
HBHC: Care: Adult Care and Support | $17,250,841 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,232,190 |
HVCT: Testing: HIV Testing and Counseling | $10,427,031 |
HTXS: Treatment: Adult Treatment | $7,782,994 |
HKID: Care: Orphans and Vulnerable Children | $4,812,239 |
HLAB: Laboratory Infrastructure | $4,236,522 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,355,455 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,329,723 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $2,301,418 |
PDCS: Care: Pediatric Care and Support | $481,307 |
PDTX: Treatment: Pediatric Treatment | $311,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$67,405,210
Countries/Regions
FHI 360:
$13,841,011
Countries/Regions
USG Aggregated Agencies:
$12,931,972
Countries/Regions
Voluntary Health Services:
$9,660,000
Countries/Regions